Branka Mijatov
St Leonards, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Control of NF-kB activity in human melanoma by bromodomain and extra-terminal protein inhibitor I-BET151.
Journal: Pigment cell & melanoma research
Published: February 23, 2014
BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 28, 2014
The epigenetic regulator I-BET151 induces BIM-dependent apoptosis and cell cycle arrest of human melanoma cells.
Journal: The Journal of investigative dermatology
Published: January 16, 2014
Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma.
Journal: Molecular oncology
Published: December 04, 2013
Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion.
Journal: The Journal of investigative dermatology
Published: November 30, 2012
The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistance.
Journal: Carcinogenesis
Published: October 23, 2012
Histone deacetylases (HDACs) as mediators of resistance to apoptosis in melanoma and as targets for combination therapy with selective BRAF inhibitors.
Journal: Advances in pharmacology (San Diego, Calif.)
Published: September 11, 2012
Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factor.
Journal: Oncogene
Published: May 16, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026